Cost-Minimisation Analysis of Saxagliptin Compared to Sitagliptin And Linagliptin As Triple Therapy In Combination With Metformin And A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.720
https://www.valueinhealthjournal.com/article/S1098-3015(14)02650-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
145
First Page :
A349
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02650-3&doi=10.1016/j.jval.2014.08.720